Joyner R W, Kumar R, Wilders R, Jongsma H J, Verheijck E E, Golod D A, Van Ginneken A C, Wagner M B, Goolsby W N
Todd Franklin Cardiac Research Laboratory, Children's Heart Center, Department of Pediatrics, Emory University, Atlanta, Georgia 30322, USA.
Biophys J. 1996 Jul;71(1):237-45. doi: 10.1016/S0006-3495(96)79220-2.
We have used pairs of cardiac cells (i.e., one real guinea pig ventricular cell and a real-time simulation of a numerical model of a guinea pig ventricular cell) to evaluate the effects on action potential conduction of a variable coupling conductance in combination with agents that either increase or decrease the magnitude of the L-type calcium current. For the cell pairs studied, we applied a direct repetitive stimulation to the real cell, making it the "leader" cell of the cell pair. We have demonstrated that significant delays in action potential conduction for a cell pair can occur either with a decreased value of coupling conductance or with an asymmetry in size such that the follower cell is larger than the leader cell. In both conditions we have shown that isoproterenol, applied to the real cell at very low concentrations, can reversibly decrease the critical coupling conductance (below which action potential conduction fails) for a cell pair with fixed cell sizes, or, for a fixed value of coupling conductance, increase the maximum allowable asymmetry in cell size for successful conduction. For either of these effects, we were able to show that treatment of the real cell with BayK 8644, which more specifically increases the magnitude of the L-type calcium current, was able to mimic the actions of isoproterenol. Treatment of the leader cell of the cell pair (the real cell) with nifedipine, which selectively lowers the magnitude of the L-type calcium current, had effects opposite those of isoproterenol or BayK 8644. The actions of nifedipine, isoproterenol, and BayK 8644 are all limited to conditions in which the conduction delay is on the order of 5 ms or more, whether this delay is caused by limited coupling conductance or by asymmetry in size of the cells. This limitation is consistent with the time course of the L-type calcium current and suggests that the effects of calcium channel blockers or beta-adrenergic blocking drugs, in addition to being selective for regions of the heart that depend on the L-type calcium current for the upstroke of the action potential, would also be somewhat selective for regions of the heart that have discontinuous conduction, either normally or because of some pathological condition.
我们使用成对的心脏细胞(即一个真正的豚鼠心室细胞和豚鼠心室细胞数值模型的实时模拟)来评估可变耦合电导与增加或减少L型钙电流幅度的药物联合使用时对动作电位传导的影响。对于所研究的细胞对,我们对真实细胞施加直接重复刺激,使其成为细胞对中的“主导”细胞。我们已经证明,对于细胞对而言,动作电位传导的显著延迟可能发生在耦合电导值降低时,或者发生在大小不对称且跟随细胞大于主导细胞的情况下。在这两种情况下,我们都表明,以非常低的浓度应用于真实细胞的异丙肾上腺素,可以可逆地降低固定细胞大小的细胞对的临界耦合电导(低于此值动作电位传导失败),或者对于固定的耦合电导值,增加成功传导时细胞大小的最大允许不对称性。对于这些效应中的任何一种,我们都能够表明,用更特异性地增加L型钙电流幅度的BayK 8644处理真实细胞,能够模拟异丙肾上腺素的作用。用选择性降低L型钙电流幅度的硝苯地平处理细胞对中的主导细胞(真实细胞),其作用与异丙肾上腺素或BayK 8644相反。硝苯地平、异丙肾上腺素和BayK 8644的作用都限于传导延迟在5毫秒或更长时间量级的情况,无论这种延迟是由有限的耦合电导还是细胞大小不对称引起的。这种限制与L型钙电流的时间进程一致,并表明钙通道阻滞剂或β-肾上腺素能阻断药物的作用,除了对依赖L型钙电流进行动作电位上升的心脏区域具有选择性外,对于正常或由于某些病理状况而具有不连续传导的心脏区域也会有一定的选择性。